Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Guiraud-Diawara A"'
Autor:
Citrome L, Eramo A, Francois C, Duffy R, Legacy SN, Offord SJ, Krasa HB, Johnston SS, Guiraud-Diawara A, Kamat SA, Rohman P
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2015, Iss Issue 1, Pp 3095-3104 (2015)
Leslie Citrome,1 Anna Eramo,2 Clement Francois,2 Ruth Duffy,3 Susan N Legacy,3 Steve J Offord,3 Holly B Krasa,3 Stephen S Johnston,4 Alice Guiraud-Diawara,5 Siddhesh A Kamat,3 Patricia Rohman3 1Department of Psychiatry and Behavioral Sciences, New Yo
Externí odkaz:
https://doaj.org/article/f52fce680c02433a94e07a79f62deb18
Autor:
Brodie, Martin J., Chung, Steve, Wade, Alan, Quelen, Céline, Guiraud-Diawara, Alice, François, Clément, Verpillat, Patrice, Shen, Vivienne, Isojarvi, Jouko
Publikováno v:
In Epilepsy Research July 2016 123:68-74
Autor:
Clément François, Alice Guiraud-Diawara, Christophe Lançon, Pierre Michel Llorca, Ann Hartry, Lene Hammer-Helmich, Djamel A. Zighed, Adrian Tanasescu, Mondher Toumi
Publikováno v:
Journal of Market Access & Health Policy, Vol 5, Iss 1 (2017)
Background: Adverse event (AE) reporting in clinical trials does not fully capture the patient-level perspective and comparing tolerability across treatments or among studies is difficult. Objective: This study was designed to develop a treatment tol
Externí odkaz:
https://doaj.org/article/83669431b5d442d38d1f6ec95264c30d
Autor:
J Y Loze, A Maguire, D. Saragoussi, K T Jørgensen, Francois-Xavier Lamy, M E Johnson, A Guiraud-Diawara
Publikováno v:
Current Medical Research and Opinion. 33:891-898
Adjunctive antipsychotic therapy can be prescribed to patients with depression who have inadequate response to antidepressants. This study aimed to describe the use of adjunctive antipsychotics over a time period that includes the authorization in 20
Autor:
Pierre-Michel Llorca, Lene Hammer-Helmich, Alice Guiraud-Diawara, Mondher Toumi, Clément François, Christophe Lançon, Ann Hartry, Adrian Tanasescu, Djamel A. Zighed
Publikováno v:
Journal of Market Access & Health Policy
Journal of Market Access & Health Policy, 2017, 5 (1), ⟨10.1080/20016689.2017.1372026⟩
Journal of Market Access & Health Policy, Taylord & Francis, 2017, 5 (1), ⟨10.1080/20016689.2017.1372026⟩
Journal of Market Access & Health Policy, Vol 5, Iss 1 (2017)
Journal of Market Access & Health Policy, 2017, 5 (1), ⟨10.1080/20016689.2017.1372026⟩
Journal of Market Access & Health Policy, Taylord & Francis, 2017, 5 (1), ⟨10.1080/20016689.2017.1372026⟩
Journal of Market Access & Health Policy, Vol 5, Iss 1 (2017)
Background: Adverse event (AE) reporting in clinical trials does not fully capture the patient-level perspective and comparing tolerability across treatments or among studies is difficult. Objective: This study was designed to develop a treatment tol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42f7a6eb7a6ed4a047fc2ce9e9e80dcd
https://hal.uca.fr/hal-01696896
https://hal.uca.fr/hal-01696896
Autor:
Clément François, Leslie Citrome, Alice Guiraud-Diawara, Stephen S. Johnston, Patricia Rohman, Steve Offord, Anna Eramo, Ruth A Duffy, Siddhesh A Kamat, Susan N Legacy, Holly Krasa
Publikováno v:
Neuropsychiatric Disease and Treatment
Leslie Citrome,1 Anna Eramo,2 Clement Francois,2 Ruth Duffy,3 Susan N Legacy,3 Steve J Offord,3 Holly B Krasa,3 Stephen S Johnston,4 Alice Guiraud-Diawara,5 Siddhesh A Kamat,3 Patricia Rohman3 1Department of Psychiatry and Behavioral Sciences, New Yo
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Christophe Lançon, Lene Hammer-Helmich, Adrian Tanasescu, Pierre-Michel Llorca, Clément François, Djamel A. Zighed, Ann Hartry, Mondher Toumi, Alice Guiraud-Diawara
Publikováno v:
Value in Health. 19:A181-A182
Autor:
Tasneem Lokhandwala, Patrice Verpillat, Pamela Landsman-Blumberg, Dana Stafkey-Mailey, A. Rouleau, Alice Guiraud-Diawara
Publikováno v:
Value in Health. 17(7)
Autor:
Jean-Michel Azorin, Caroline Marre, L. Sawyer, K. Hansen, Stacey Chang, Claudia Rinciog, Alice Guiraud-Diawara
Publikováno v:
Journal of medical economics. 17(7)
Around one-third of patients with bipolar I disorder (BD-I) experience mixed episodes, characterized by both mania and depression, which tend to be more difficult and costly to treat. Atypical antipsychotics are recommended for the treatment of mixed